Viking Therapeutics Inc (VKTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

12340 EL CAMINO REAL, SUITE 250 SAN DIEGO, CA 92130

Viking Therapeutics Inc operates as a biopharmaceutical company. The Company focuses on the development of therapeutics for patients suffering from metabolic and endocrine disorders.

Data as of 2020-05-24
Market Cap577.142 Million Shares Outstanding72.596 Million Avg 30-day Volume1.773 Million
P/E Ratio Dividend Yield EPS-0.43
Price/Sales Price cash flow ratio Price free cash flow ratio-22.3
Book Value3.7 Price to Tangible Book2.15 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.099892
BETA2.07288 52-week High/Low8.87 / 3.26 Stddev0.278524
View SEC Filings from VKTX instead.

View recent insider trading info

Funds Holding VKTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VKTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WEBSTER STEPHEN W

  • Director
0 2020-04-30 1

MORNEAU MICHAEL VP, FINANCE AND ADMINISTRATION

  • Officer
0 2020-03-31 5

FOEHR MATTHEW W PRESIDENT AND COO

  • Officer
157,449 2020-03-13 1

ROUAN SARAH KATHRYN

  • Director
10,850 2020-02-06 3

LIAN BRIAN PRESIDENT & CEO

  • Officer
  • Director
1,704,312 2020-01-19 2

SINGLETON J MATTHEW

  • Director
0 2020-01-02 1

MACARTNEY LAWSON

  • Director
0 2020-01-02 1

ROWLAND CHARLES A JR

  • Director
0 2020-01-02 1

MASAMUNE HIROKO CHIEF DEVELOPMENT OFFICER

  • Officer
141,063 2019-01-03 0

LIGAND PHARMACEUTICALS INC

  • 10% Owner
6,038,083 2017-07-13 0

HANLEY ROCHELLE CHIEF MEDICAL OFFICER

  • Officer
160,836 2016-05-04 0

DINERMAN MICHAEL CHIEF OPERATING OFFICER

  • Officer
694,116 2015-05-04 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MORNEAU MICHAEL - Officer VP, FINANCE AND ADMINISTRATION

2020-03-31 A 15,000 a 15,000 0.00 direct

Elevate your investments